跳至主導覽 跳至搜尋 跳過主要內容

Predictive model for treatment outcomes of peripheral T-cell lymphoma, not otherwise specified, in Taiwanese patients

  • Ning Chun Chen
  • , Hung Chang
  • , Ming Chung Kuo
  • , Tung Liang Lin
  • , Lee Yung Shih
  • , Wen Yu Chuang
  • , Hsiao Wen Kao*
  • *此作品的通信作者
  • Chang Gung Memorial Hospital
  • Chang Gung University

研究成果: 期刊稿件 › 文章 › 同儕審查

4 引文 斯高帕斯(Scopus)

摘要

PURPOSE: We aimed to explore the clinical outcomes and prognostic factors for PTCL-NOS patients in the real world.

METHODS: Clinical data were retrospectively collected from adult patients with PTCL-NOS treated at a single center in Taiwan.

RESULTS: 104 PTCL-NOS patients with a median age of 53.0 years were enrolled. Patients with the International Prognostic Index (IPI) or prognostic index for peripheral T-cell lymphoma (PIT) scores of zero had a longer overall survival (OS) and progression free survival (PFS), while patients with IPI or PIT scores ≥1 did poorly. For patients who are eligible for transplantation, the use of pralatrexate as salvage chemotherapy has shown better OS (2-year OS 83.3% vs. 24.4%, P = 0.011) compared to patients who did not. By multivariate analysis, age >60 years, male, B symptoms, ECOG >1, lung involvement, and thrombocytopenia were independent adverse factors for OS. Incorporating factors in multivariate analysis, we established a novel predictive index for PTCL-NOS which efficiently stratifies patients into low (0-1 factor), intermediate-1 (2 factors), intermediate-2 (3 factors), and high risk (4-6 factors) groups with 2-year OS rates of 81.5%, 32.9%, 8.8%, and 0%, respectively (P < 0.001).

CONCLUSION: PTCL-NOS patients have a dismal prognosis in Taiwan. Novel agents may improve the outcomes of PTCL-NOS patients. The usefulness of the novel prognostic index for PTCL-NOS needs further validation.

原文英語
頁(從 - 到)188-197
頁數10
期刊Journal of the Formosan Medical Association
卷123
發行號2
DOIs
出版品狀態已出版 - 02 2024

文獻附註

Copyright © 2023 Formosan Medical Association. Published by Elsevier B.V. All rights reserved.

UN SDG

此研究成果有助於以下永續發展目標

  1. SDG3 健康與福祉
    SDG3 健康與福祉

指紋

深入研究「Predictive model for treatment outcomes of peripheral T-cell lymphoma, not otherwise specified, in Taiwanese patients」主題。共同形成了獨特的指紋。

引用此